VIP Purity: HPLC & MS Verification
Vasoactive Intestinal Peptide (VIP) is a complex 28-amino acid basic neuropeptide requiring rigorous analytical characterization to ensure data integrity in cell culture and biochemical assays. PX1 Research supplies laboratory-grade VIP verified via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to eliminate synthesis contaminants and truncation sequences.
Quick answer
Vasoactive Intestinal Peptide (VIP) is a complex 28-amino acid basic neuropeptide requiring rigorous analytical characterization to ensure data integrity in cell culture and biochemical assays. PX1 Research supplies laboratory-grade VIP verified via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to eliminate synthesis contaminants and truncation sequences.
Key takeaways
- Vasoactive Intestinal Peptide (VIP) is a 28-amino acid peptide belonging to the glucagon/secretin superfamily of regulatory peptides.
- In cell culture models and tissue preparation studies, peptide impurities act as unquantified variables that diminish inter-assay reproducibility.
- Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) serves as the primary analytical tool for quantifying the purity profile of synthetic VIP.
- While RP-HPLC separates chemical species based on hydrophobicity, Mass Spectrometry (MS) provides exact molecular weight determination to verify correct primary sequence assembly.
Structural Complexity and Chemical Identity of Vasoactive Intestinal Peptide
Vasoactive Intestinal Peptide (VIP) is a 28-amino acid peptide belonging to the glucagon/secretin superfamily of regulatory peptides. Its primary sequence—His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2—contains several labile residues, including methionine at position 17 and multiple basic residues (lysine and arginine) that present significant challenges during solid-phase peptide synthesis (SPPS). When evaluating VIP purity for controlled laboratory investigations, investigators must account for potential side reactions, such as methionine oxidation, aspartic acid isomerization, and incomplete coupling sequences.
Due to its structural overlap with other class B1 G protein-coupled receptor (GPCR) ligands, high-purity VIP is essential when measuring receptor binding kinetics, cAMP accumulation, or downstream signaling cascades. In vitro assays evaluating VPAC1 and VPAC2 receptor activation can be significantly compromised if sequence variants or deletion peptides are present in the working solution. Maintaining rigorous chemical purity ensures that experimental responses reflect true ligand-receptor interactions rather than artifacts generated by synthesis byproducts.
The Impact of Impurities on Preclinical and In Vitro Assays
In cell culture models and tissue preparation studies, peptide impurities act as unquantified variables that diminish inter-assay reproducibility. Truncated peptide fragments generated during synthesis may retain partial binding affinity for target receptors without triggering intracellular signaling pathways, effectively acting as competitive antagonists. Conversely, aggregated species or oxidized methionine isoforms may induce off-target cytotoxicity or alter solubility profiles in aqueous buffers.
Establishing rigorous peptide purity standards is particularly vital when conducting quantitative bioassays, such as fluorescence polarization or surface plasmon resonance (SPR). Non-target sequences obscure baseline signals and distort kinetic binding constants (Kd, Kon, Koff). Supplying laboratory research with VIP characterized at or above 99% purity minimizes these analytical discrepancies, providing researchers with predictable, baseline-verified performance across successive experimental runs.
Reverse-Phase HPLC Analysis: Separation and Quantitative Purity Determination
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) serves as the primary analytical tool for quantifying the purity profile of synthetic VIP. The hydrophobic stationary phase (typically C18 or C4 silica matrices) separates the target 28-amino acid sequence from closely eluting hydrophobic impurities, such as protecting-group adducts, deletion sequences, and diastereomers. By utilizing trifluoroacetic acid (TFA) or formic acid as ion-pairing agents in an acetonitrile/water gradient, RP-HPLC provides sharp chromatographic resolution.
At PX1 Research, every lot of VIP undergoes ultra-high performance liquid chromatography (UHPLC) analysis equipped with photodiode array (PDA) detection set at 214 nm and 280 nm. The 214 nm wavelength detects peptide backbone amide bonds, offering an accurate total area percentage calculation, while 280 nm monitors aromatic side chains (tyrosine and phenylalanine). Chromatograms are evaluated to ensure the main peak accounts for ≥99% of total integrated peak area, confirming the virtual absence of shorter sequence fragments or hydrophobic impurities. Detailed methodologies can be reviewed in our comprehensive HPLC and mass spectrometry guide.
Mass Spectrometry Verification: Confirming Sequence Integrity and Molecular Weight
While RP-HPLC separates chemical species based on hydrophobicity, Mass Spectrometry (MS) provides exact molecular weight determination to verify correct primary sequence assembly. Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) MS is used to determine the mass-to-charge ratio (m/z) of the intact VIP molecule.
The theoretical monoisotopic molecular weight of full-length C-terminally amidated VIP is 3325.8 Da. High-resolution mass spectrometry detects multiple protonated charge states ([M+3H]3+, [M+4H]4+, [M+5H]5+) that confirm the structural mass within tight tolerance limits (±0.5 Da). MS analysis eliminates the risk of misidentifying sequence-scrambled isomers or peptides containing undetected amino acid substitutions, ensuring that the material delivered for in vitro research corresponds precisely to the targeted primary structure.
Endotoxin Testing and Bioburden Control in Cell Culture Models
Bacterial endotoxins (lipopolysaccharides, LPS) represent a severe confounding factor in cellular assays, particularly those involving macrophages, neuroglia, or endothelial cell cultures. Endotoxins trigger toll-like receptor 4 (TLR4) activation, inducing pro-inflammatory cytokine expression (e.g., TNF-alpha, IL-1beta) that can completely mask or distort the biological actions of VIP in immune or neurochemical models.
To protect experimental validity, PX1 Research subjects all research peptides to rigorous Chromogenic Recombinant Factor C (rFC) or Limulus Amebocyte Lysate (LAL) testing in accordance with USP <85> guidelines. Our VIP lots are certified to contain <0.01 EU/µg of endotoxin. Operating out of ISO 17025 accredited laboratories and sterile, GMP-compliant processing facilities, we ensure that bioburden is controlled at every stage from synthesis to final lyophilization. Further details on bioburden protocols are available in our guide on endotoxin testing methods.
Comparative Analysis: VIP vs. PACAP-38, Secretin, and GHRH Purity Profiles
When designing comparative neuropeptide assays, researchers frequently evaluate VIP alongside structurally or functionally related peptides within the secretin/glucagon family. Understanding the analytical characteristics of each compound is essential for designing robust experimental controls:
For instance, PACAP-38 shares significant sequence homology with VIP at its N-terminus and activates the same VPAC1 and VPAC2 receptors, in addition to its selective PAC1 receptor. However, PACAP-38 contains 38 amino acids, making its synthesis significantly more complex and increasing the likelihood of truncated deletion sequences during SPPS. Similarly, secretin displays structural conservation but differs in its target receptor specificity (secretin receptor) and physical stability in solution. Meanwhile, GHRH (Growth Hormone-Releasing Hormone) represents another 44-amino acid helical peptide in this class, where oxidation of methionine residues poses a comparable analytical challenge. Maintaining >99% purity across all these comparative ligands prevents cross-receptor activation artifacts caused by shared truncated fragments.
Lyophilization, Matrix Integrity, and Laboratory Reconstitution Protocols
Standard solid-state VIP is supplied as a lyophilized cake containing the trifluoroacetate or acetate counter-ion salt. Proper handling and storage conditions are required to maintain chemical stability over extended storage periods. Lyophilized VIP should be stored at -20°C or -80°C in a desiccated environment to prevent atmospheric moisture uptake, which accelerates hydrolysis and methionine oxidation.
For laboratory reconstitution, researchers should reconstitute VIP in sterile, deionized water or dilute acetic acid (0.1% v/v) before diluting into final assay buffers such as Phosphate-Buffered Saline (PBS, pH 7.4). Avoid repeated freeze-thaw cycles by aliquoting the reconstituted solution into single-use microcentrifuge tubes. Complete procedures for handling sensitive neuropeptides are detailed in our manual on lyophilized peptide reconstitution.
Manufacturing Standards and Quality Assurance at PX1 Research
PX1 Research synthesizes research peptides exclusively within the USA using state-of-the-art automated solid-phase peptide synthesizers. By controlling step-wise coupling efficiency, Fmoc-deprotection kinetics, and final cleavage conditions, our production facility minimizes unwanted side reactions before purification.
Post-synthesis, preparative HPLC isolates the target VIP fraction. The purified eluate is transferred to ISO 7 cleanroom suites for sterile filtration and controlled lyophilization. Institutional facilities and laboratory accounts seeking high-volume or custom-grade batches can review specialized supply terms via our wholesale research portal. Every lot distributed is backed by a verifiable, lot-specific Certificate of Analysis (COA).
Verifying COA Authenticity for Laboratory Quality Control
A reliable Certificate of Analysis must provide complete transparency rather than summary assertions. Independent, third-party laboratory verification ensures that analytical testing is unbiased and conducted according to international standards.
PX1 Research includes lot-specific COAs with every VIP shipment. Each document features raw RP-HPLC chromatograms with integrated peak tables, full-scan ESI-MS mass spectra indicating observed vs. theoretical mass, LAL endotoxin quantification results, and net peptide content determination (nitrogen analysis). This comprehensive documentation allows laboratory compliance officers and principal investigators to verify batch uniformity before initiating sensitive preclinical research.
Frequently Asked Questions
What is the typical HPLC purity threshold for PX1 Research VIP?
PX1 Research supplies VIP verified at ≥99% purity by RP-HPLC. The lot-specific Certificate of Analysis displays the raw chromatogram and peak integration table confirming the purity percentage.
How is molecular weight verified for VIP?
Molecular weight is confirmed using Mass Spectrometry (ESI-MS or MALDI-TOF). The analytical spectrum must demonstrate the correct molecular ion peak corresponding to VIP's theoretical mass of 3325.8 Da.
Why is endotoxin testing critical for VIP used in cell culture models?
Endotoxins (LPS) trigger inflammatory signals via TLR4 receptors in immune and neural cell lines. Low endotoxin limits (<0.01 EU/µg) prevent background cellular activation that could obscure VIP-specific VPAC receptor signaling.
How should VIP be reconstituted for in vitro laboratory applications?
VIP should be reconstituted using sterile, cold deionized water or 0.1% acetic acid solution under a laminar flow hood. Once dissolved, it can be diluted into working assay buffers (e.g., PBS) and aliquoted to avoid freeze-thaw degradation.
What counter-ion is present in lyophilized VIP?
Synthetic VIP is typically isolated as a trifluoroacetate (TFA) or acetate salt resulting from HPLC purification buffers. The specific salt form and net peptide content are documented on the lot-specific COA.
What are the recommended storage conditions for VIP?
Lyophilized VIP should be stored at -20°C or -80°C in a desiccated container away from light. Reconstituted aliquots should be kept frozen at -80°C and used promptly upon thawing.
How does VIP compare structurally to PACAP-38?
VIP (28 amino acids) and PACAP-38 (38 amino acids) belong to the same peptide family and share structural homology at their N-termini. Both target VPAC1 and VPAC2 receptors, but PACAP-38 also binds selectively to the PAC1 receptor.
Where is PX1 Research VIP synthesized and tested?
PX1 Research peptides are synthesized in the USA in GMP-compliant facilities and undergo analytical testing at independent ISO 17025 accredited laboratories.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.